When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CRMD - CorMedix +7% on FDA acceptance for filing and priority review of Defencath
CorMedix Inc.
FDA has accepted CorMedix (NYSEMKT:CRMD) +7% filing of new drug application for Defencath its product candidate to be used as a catheter lock solution in hemodialysis patients for the prevention of catheter related blood stream infections.
More news on: CorMedix Inc., Stocks on the move, Healthcare stocks news,